Terms: = Head and neck cancer AND RUNX1T1, ENSG00000079102, 862
115 results:
1. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
[TBL] [Abstract] [Full Text] [Related]
2. A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
Zou X; Feng ZK; Hua YJ; Liu YP; Xie YL; Ouyang YF; Liu YL; Wang ZQ; You R; Ding X; Yang Q; Yu ZK; Huang PY; Wang SL; Chen MY
Head Neck; 2024 Feb; 46(2):291-299. PubMed ID: 37974339
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness of postoperative imaging surveillance strategies for nonfunctional pituitary adenomas after resection with curative intent.
Caulley L; Dijk SW; Krijkamp E; Dong SX; Alkherayf F; Amrani L; Doyle MA; Eid A; Johnson-Obaseki S; Khoury M; Malcolm J; Mavedatnia D; Sahlollbey N; Schramm D; Whelan J; Thavorn K; Kilty S; Hunink MGM
J Neurosurg; 2023 Nov; 139(5):1207-1215. PubMed ID: 37922550
[TBL] [Abstract] [Full Text] [Related]
4. Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
Mavromati M; Saiji E; Demarchi MS; Lenoir V; Seipel A; Kuczma P; Jornayvaz FR; Becker M; Fernandez E; De Vito C; Triponez F; Leboulleux S
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855426
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of three-dimensional and two-dimensional thoracoscopic segmentectomy in lung cancer.
Shen MS; Hsieh MY; Lin CH; Wang BY
Asian J Surg; 2023 Jul; 46(7):2657-2661. PubMed ID: 37430487
[TBL] [Abstract] [Full Text] [Related]
7. Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer.
Zhang B; Zhao H; Wu X; Gong L; Yang D; Li X; Chen X; Li J; Wang W; Wu J; Xiao Q
Front Immunol; 2023; 14():1066527. PubMed ID: 36825006
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract] [Full Text] [Related]
9. Development of a machine learning-based fine-grained risk stratification system for thyroid nodules using predefined clinicoradiological features.
Ha EJ; Lee JH; Lee DH; Na DG; Kim JH
Eur Radiol; 2023 May; 33(5):3211-3221. PubMed ID: 36600122
[TBL] [Abstract] [Full Text] [Related]
10. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia.
Zeng S; Chang CH; Sun M; Chen WM; Wu SY; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):576-584. PubMed ID: 36562311
[TBL] [Abstract] [Full Text] [Related]
12. Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals.
Bukasa-Kakamba J; Bayauli P; Sabbah N; Bidingija J; Atoot A; Mbunga B; Nkodila A; Atoot A; Bangolo AI; M'Buyamba-Kabangu JR
Sci Rep; 2022 Nov; 12(1):18442. PubMed ID: 36323772
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
Zhang D; Liu J; Zheng M; Meng C; Liao J
World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
[TBL] [Abstract] [Full Text] [Related]
14. Coexisting Papillary and Anaplastic Thyroid cancer: Elucidating the Spectrum of Aggressive Behavior.
Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
[TBL] [Abstract] [Full Text] [Related]
15. Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis.
Yin L; Hou S; Hou LL; Pu CC
Endocrine; 2023 Feb; 79(2):331-341. PubMed ID: 36207552
[TBL] [Abstract] [Full Text] [Related]
16. Predictive Value of Magnetic Resonance Imaging Multi-parametric Analysis for Malignant Transformation of Sinonasal Inverted Papilloma: A Comprehensive Prediction Model.
Zhang D; Zhang J; Zhou J; Xu J; Guo Y; Zhang Z; Liu Y; Chen Y; Wang S; Liu C
Curr Med Imaging; 2023; 19(6):596-604. PubMed ID: 36173080
[TBL] [Abstract] [Full Text] [Related]
17. Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study.
Sitanggang JS; Siregar KB; Sitanggang HH; Sprinse Vinolina N
F1000Res; 2021; 10():975. PubMed ID: 36051540
[No Abstract] [Full Text] [Related]
18. Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: Retrospective study based on SEER database.
Chen KH; Jiang YT; Zhao R; Sun YC; Zhu XD
Head Neck; 2022 Dec; 44(12):2649-2659. PubMed ID: 36054033
[TBL] [Abstract] [Full Text] [Related]
19. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
Pape M; Vissers PAJ; Bertwistle D; McDonald L; Beerepoot LV; van Berge Henegouwen MI; Lagarde SM; Mook S; Mohammad NH; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Br J Surg; 2022 Nov; 109(12):1264-1273. PubMed ID: 35998093
[TBL] [Abstract] [Full Text] [Related]
20. The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Zhang X; Rui M; Lin C; Li Z; Wei D; Han R; Ju H; Ren G
Cancer Med; 2023 Feb; 12(3):2702-2712. PubMed ID: 35975731
[TBL] [Abstract] [Full Text] [Related]
[Next]
